Evidence map›Paper›PMID 39995254›Full record

Observational studyFuture oncology (London, England)2025

Hepatic steatosis development as a long-term complication among testicular germ cell tumor survivors.

Erman Akkus, Ali Devrim Karaosmanoğlu, Başak Gülpınar, Evren Süer, Yüksel Ürün

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Future oncology (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Erman AkkusFaculty of Medicine, Department of Medical Oncology, Ankara University, Ankara, Türkiye.ORCID 0000-0002-7531-7817
Ali Devrim KaraosmanoğluFaculty of Medicine, Department of Radiology, Hacettepe University, Ankara, Türkiye.
Başak GülpınarFaculty of Medicine, Department of Radiology, Ankara University, Ankara, Türkiye.
Evren SüerFaculty of Medicine, Department of Urology, Ankara University, Ankara, Türkiye.
Yüksel ÜrünFaculty of Medicine, Department of Medical Oncology, Ankara University, Ankara, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatic steatosis (HS) development and its risk factors in testicular germ cell tumor (TGCT) survivors have not been investigated.

methodsThe study was designed as a retrospective observational study. Patients with existing HS at diagnosis were excluded. Serial imaging was utilized to detect HS.

resultsA total of 106 TGCT survivors were included. HS developed in 57% (

conclusionHS may be considered a long-term complication in TGCT patients. The risk is associated with baseline BMI. Diagnosis and management of HS should be implemented in the survivorship care plan of TGCT survivors.

Indexed as

Cancer SurvivorsFatty LiverNeoplasms, Germ Cell and EmbryonalTesticular NeoplasmsAdultBody Mass IndexFollow-Up StudiesHumansMaleMiddle AgedRetrospective StudiesRisk FactorsYoung AdultBMIbody mass indexfatty livergerm cell tumorhepatic steatosissurvivorTesticular

Identifiers

PMID39995254
PMCPMC11938976

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.